Telix Pharmaceuticals Limited
USD10.66
-0.20 (-1.84%)
CEO
Christian Behrenbruch
IPO Date
2024-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
AU
Open
$10.67
Prev. Close
$10.86
Day Low
$10.62
Day High
$10.74
52W Low
$6.28
52W High
$16.98
Market Cap
$3.61B
Volume
0.13M
| $0.00 |
| 18 May 2026 | Rivas Maria | director: | Disposed | 0 | $0.00 |
| 6 May 2026 | Behrenbruch Christian | director, officer: MD & Group CEO | P-Purchase | Acquired | 34,500 | $14.48 |
| 6 May 2026 | Behrenbruch Christian | director, officer: MD & Group CEO | P-Purchase | Acquired | 33,435 | $14.87 |
| 1 Apr 2026 | Smith Darren Charlton | Group Chief Financial Officer | M-Exempt | Acquired | 1,111 | $0.00 |
| 1 Apr 2026 | Smith Darren Charlton | Group Chief Financial Officer | M-Exempt | Disposed | 1,111 | $0.00 |
| 1 Apr 2026 | Cade David Norman | Group Chief Medical Officer | Disposed | 0 | $0.00 |
| 1 Apr 2026 | Cade David Norman | Group Chief Medical Officer | Disposed | 78,189 | $4.95 |
| 1 Apr 2026 | Cade David Norman | Group Chief Medical Officer | Disposed | 84,293 | $6.90 |